OSCR

ROS-responsive nanoplatform-mediated targeted intranasal delivery of Piezo2 siRNA for the treatment of trigeminal neuralgia.

Overview

Authors: Yangbin Wang1, Li Zhao1, Jiaming Chen2, Peiqi Cao1, Yuanyuan Li1, Qingling Wang1, Jingxia Xiang1, Shaomei Chen1, Shiling Liu1, Haoxiong Zhang1, Daoshu Luo1, Mei Lin2, Feng Wang1
ORCID iDs: Mei Lin, Feng Wang
  1. Institute of Clinical Applied Anatomy, Department of Human Anatomy, School of Basic Medical Sciences, Fujian Medical University, Key Laboratory of Brain Aging and Neurodegenerative Diseases of Fujian Province, Fuzhou, China
  2. Department of Medicinal Chemistry, School of Pharmacy, Fujian Medical University, Fuzhou, China
Institutions: Fujian Medical University (China)
Journal: Materials today. Bio, volume 39, article 103431
Dates: received 15 April 2026; accepted 3 July 2026; published online 9 July 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.mtbio.2026.103431 · PMID 42518694 · PMCID PMC13382426 · OpenAlex W7167795527
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: pain (population), clinical / translational (subfield)
Methods: Statistics
Keywords: Trigeminal neuralgia, Piezo2, Reactive oxygen species, Nanoparticles, Intranasal delivery
Topic: Advanced Drug Delivery Systems (Pharmaceutical Science, Pharmacology, Toxicology and Pharmaceutics), according to OpenAlex
Funding: Fujian Medical University; Fujian Provincial Natural Science Foundation (2025J01694, 2023Y9005)
Citations: not cited yet (Europe PMC); 41 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request

Read it in the paper: doi.org/10.1016/j.mtbio.2026.103431.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Feng Wang (0000-0002-8637-6660); removed Feng Wang

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 13 authors, 5 keywords, 2 funders, 41 references.

Cite

This paper

Wang, Y., Zhao, L., Chen, J., Cao, P., Li, Y., Wang, Q., Xiang, J., Chen, S., Liu, S., Zhang, H., Luo, D., Lin, M., & Wang, F. (2026). ROS-responsive nanoplatform-mediated targeted intranasal delivery of Piezo2 siRNA for the treatment of trigeminal neuralgia. Materials today. Bio, 39, 103431. https://doi.org/10.1016/j.mtbio.2026.103431

BibTeX

@article{wang2026ros,
author = {Wang, Yangbin and Zhao, Li and Chen, Jiaming and Cao, Peiqi and Li, Yuanyuan and Wang, Qingling and Xiang, Jingxia and Chen, Shaomei and Liu, Shiling and Zhang, Haoxiong and Luo, Daoshu and Lin, Mei and Wang, Feng},
title = {{ROS-responsive nanoplatform-mediated targeted intranasal delivery of Piezo2 siRNA for the treatment of trigeminal neuralgia}},
journal = {Materials today. Bio},
year = {2026},
month = jul,
volume = {39},
pages = {103431},
publisher = {Elsevier},
issn = {2590-0064},
doi = {10.1016/j.mtbio.2026.103431},
url = {https://doi.org/10.1016/j.mtbio.2026.103431},
pmid = {42518694},
pmcid = {PMC13382426}
}

RIS

TY - JOUR
AU - Wang, Yangbin
AU - Zhao, Li
AU - Chen, Jiaming
AU - Cao, Peiqi
AU - Li, Yuanyuan
AU - Wang, Qingling
AU - Xiang, Jingxia
AU - Chen, Shaomei
AU - Liu, Shiling
AU - Zhang, Haoxiong
AU - Luo, Daoshu
AU - Lin, Mei
AU - Wang, Feng
TI - ROS-responsive nanoplatform-mediated targeted intranasal delivery of Piezo2 siRNA for the treatment of trigeminal neuralgia
T2 - Materials today. Bio
J2 - Mater Today Bio
PY - 2026
DA - 2026/07/09
VL - 39
SP - 103431
SN - 2590-0064
PB - Elsevier
DO - 10.1016/j.mtbio.2026.103431
UR - https://doi.org/10.1016/j.mtbio.2026.103431
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.mtbio.2026.103431",
"type": "article-journal",
"title": "ROS-responsive nanoplatform-mediated targeted intranasal delivery of Piezo2 siRNA for the treatment of trigeminal neuralgia",
"container-title": "Materials today. Bio",
"author": [
{
"family": "Wang",
"given": "Yangbin"
},
{
"family": "Zhao",
"given": "Li"
},
{
"family": "Chen",
"given": "Jiaming"
},
{
"family": "Cao",
"given": "Peiqi"
},
{
"family": "Li",
"given": "Yuanyuan"
},
{
"family": "Wang",
"given": "Qingling"
},
{
"family": "Xiang",
"given": "Jingxia"
},
{
"family": "Chen",
"given": "Shaomei"
},
{
"family": "Liu",
"given": "Shiling"
},
{
"family": "Zhang",
"given": "Haoxiong"
},
{
"family": "Luo",
"given": "Daoshu"
},
{
"family": "Lin",
"given": "Mei"
},
{
"family": "Wang",
"given": "Feng"
}
],
"container-title-short": "Mater Today Bio",
"volume": "39",
"page": "103431",
"DOI": "10.1016/j.mtbio.2026.103431",
"PMID": "42518694",
"PMCID": "PMC13382426",
"ISSN": "2590-0064",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.mtbio.2026.103431",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
9
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s10194-026-02419-7 [code]
Transcriptional correlates of structure-function coupling plasticity in trigeminal neuralgia: unveiling the synaptic and metabolic associations.
Journal: The journal of headache and pain
In common: pain, 3 references
[2] doi:10.1002/advs.202516310
A Tac1-Expressing Brainstem Pathway Underlies the Pathogenesis of Trigeminal Neuralgia.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: pain, 2 references
[3] doi:10.34133/research.1294
Platelets Orchestrate a Neuroimmune Axis Driving Cutaneous Inflammation and Itch.
Journal: Research (Washington, D.C.)
In common: 2 references
[4] doi:10.2147/jpr.s624205
Comparative Efficacy of Invasive and Non-Invasive Neuromodulation Techniques for Chronic Central and Peripheral Neuropathic Pain: A Systematic Review and Network Meta-Analysis.
Journal: Journal of pain research
In common: pain, clinical / translational, 1 reference
[5] doi:10.1002/advs.202523223
VDAC1 Upregulation Induces Hyperexcitability of Nociceptive Sensory Neurons Via Enhanced Mitochondrial Atp Efflux in Neuropathic Pain.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: pain, 1 reference
[6] doi:10.1016/j.stemcr.2026.102971
A highly efficient method to differentiate CGRP-expressing peptidergic nociceptors from human induced pluripotent stem cells.
Journal: Stem cell reports
In common: pain, 1 reference
[7] doi:10.1093/braincomms/fcag220 [code]
When pain becomes self: limbic-default mode network hyperconnectivity predicts microvascular decompression failure in trigeminal neuralgia.
Journal: Brain communications
In common: pain, 1 reference
[8] doi:10.1038/s41467-026-71418-8 [code]
Deep visual proteomics uncovers nociceptor diversity and pain targets.
Journal: Nature communications
In common: pain, 1 reference
[9] doi:10.3390/biology15141179
Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma.
Journal: Biology
In common: clinical / translational, 1 reference
[10] doi:10.1038/s41467-026-76927-0 [code]
State-dependent binding of the wedge domain controls inactivation of the mechanosensitive ion channel PIEZO1.
Journal: Nature communications
In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.